Single-Dose Carboplatin Equal to RT in Seminoma
Single-Dose Carboplatin Equal to RT in Seminoma
Mary Ellen Schneider
20080501
2008 Jun 1
ASCO
Find more items about these cancer types:
Single-Dose Carboplatin Equal to RT in Seminoma
(00:04:49) ASCO, 2008 Jun 1, Mary Ellen Schneider
Dr. Tim Oliver is Sir Maxwell Joseph Chair of Medical Oncology, St. Bartholomew's and The Royal London Hospital School of Medicine and Dentistry, London.
A single dose of adjuvant carboplatin prevented 75% of recurrences and decreased contralateral tumors by 78% in an MRC/EORTC trial comparing this chemotherapy to radiation in men with stage I seminoma.
/Images/Oliver_tcm8-137230.jpg
See related videos to:
ASCO 2008, Clinical Trials
